Research gaps and Health Technology Assessment
Main Author: | Leela Barham |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd Medical Publishers
2014-06-01
|
Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
Subjects: | |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/926 |
Similar Items
-
Appraisals by Health Technology Assessment Agencies of Economic Evaluations Submitted as Part of Reimbursement Dossiers for Oncology Treatments: Evidence from Canada, the UK, and Australia
by: Graeme Ball, et al.
Published: (2022-10-01) -
Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myeloma
by: Xavier Armoiry, et al.
Published: (2019-01-01) -
New Health Technologies: A UK Perspective; Comment on “Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies”
by: Nassim Parvizi, et al.
Published: (2017-12-01) -
Research gaps identified in Iran’s health technology assessment reports
by: Farideh Mohtasham, et al.
Published: (2023-12-01) -
Using Evidence: Pitfalls, Practicalities and Positive Benefits
by: Gillian Leng
Published: (2016-12-01)